Albany, NY -- (SBWIRE) -- 07/20/2018 -- Factor assays are mainly undertaken during prolongation of the Activated Partial Thromboplastin Time (APTT) and Partial Thromboplastin Time (PTT) resulting in the deficiency of one or more clotting proteins. Overall a basic general principle is followed by all functional clotting factor assays that involves specific plotting/clotting time from either PTT or APTT depending on which factor it’s being assayed against sample dilution. A quantitative assay of an individual clotting factor is essential to identify inherited deficiency and to monitor replacement therapy and sometimes helps to distinguish acquired defects e.g. disseminated intravascular coagulation (DIC), vitamin K deficiency, inhibitors.
In a decade, it has been forecasted that growing cost pressures in major industrialized nations and continuous technological advances would drastically change coagulation testing practice. While automated instruments market would supplement the growth of Factor Assays Market with new sensitive and specific markers of homeostasis. Opportunities for application of factor assays will increase mainly into quality control of products and services due to technological development and standardization of its various methods. Decentralization of the factor assay testing would occur due to continuous contraction of hospital system and technical advances that will create additional opportunities and challenges for suppliers.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1867
North America is the largest factor assay market globally followed by Europe as most of the diagnostic testing is supplemented with technological superiority, R&D investment and increase in acceptance for time efficient testing techniques. Asia-Pacific is the growing market because of periodic shift of R&D functions from companies based in the U.S and Western Europe.
Some of the key players of this market are Abbott, Werfen Group (Instrumentation Laboratory), Avocet Medical, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Helena Laboratories, HYPHEN BioMed, Hoffman-La Roche, Seimens AG, Trinity Biotech PLC and others.
Enquiry for discount on this report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1867